Emil Lou

Physician-Scientist, Assistant Professor

Accepting PhD Students

20012022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

I am a physician-scientist with a strong interest and a translational approach to investigation of solid tumor malignancies at the cellular and molecular level. As a fellowship-trained and practicing medical oncologist and neuro-oncologist, I have a strong interest in a ‘bedside-to-bench-and-back’ approach to translational oncology and laboratory research. At the national level, I served on the American Society of Clinical Oncology (ASCO) Scientific Committee for GI Cancers (2012-15). Identifying pertinent clinical problems in oncology that can be investigated in the laboratory setting is a high priority for our research program and collaborative efforts. I am board-certified in medical oncology, neuro-oncology, and internal medicine.

Research interests

  • intercellular communication
  • cancer
  • tumor microenvironment
  • cancer cell biology

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 11 Similar Profiles
Nanotubes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Survival Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Brain Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2022

Cell Communication
Neoplasms
Radiosurgery
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
Neoplasms
Nanotubes
Pancreatic Neoplasms
Drug Therapy

Research Output 2001 2019

Circulating Neoplastic Cells
Platinum
MicroRNAs
Biomarkers
Prospective Studies
Adjuvant Chemotherapy
Pancreatic Neoplasms
Survival
Drug Therapy
Medicare
HhAntag691
Medulloblastoma
Genome
Primitive Neuroectodermal Tumors
Basal Cell Carcinoma
Young Adult
Vaccination
Cross-Sectional Studies
Papillomavirus Vaccines
Telemedicine

Intercellular transfer of oncogenic KRAS via tunneling nanotubes introduces intracellular mutational heterogeneity in colon cancer cells

Desir, S., Wong, P., Turbyville, T., Chen, D., Shetty, M., Clark, C., Zhai, E., Romin, Y., Manova-Todorova, K., Starr, T., Nissley, D. V., Steer, C. J., Subramanian, S. & Lou, E., Jul 1 2019, In : Cancers. 11, 7, 892.

Research output: Contribution to journalArticle

Open Access
Kirsten murine sarcoma virus
Nanotubes
Oncogenic Viruses
Parvovirus
Colonic Neoplasms